Evidence map›Paper›PMID 21702921›Full record

ArticleAnnals of clinical microbiology and antimicrobials2011

Comparative diffusion assay to assess efficacy of topical antimicrobial agents against Pseudomonas aeruginosa in burns care.

Fabien Aujoulat, Françoise Lebreton, Sara Romano, Milena Delage, Hélène Marchandin, Monique Brabet, Françoise Bricard, Sylvain Godreuil, Sylvie Parer, Estelle Jumas-Bilak

Abstract readComparative Study
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fabien AujoulatUMR5119, Unité de Bactériologie, Faculté de Pharmacie, Université Montpellier 1, 15 Avenue Charles Flahault, Montpellier Cedex 5, France.
Françoise Lebreton
Sara Romano
Milena Delage
Hélène Marchandin
Monique Brabet
Françoise Bricard
Sylvain Godreuil
Sylvie Parer
Estelle Jumas-Bilak

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeverely burned patients may develop life-threatening nosocomial infections due to Pseudomonas aeruginosa, which can exhibit a high-level of resistance to antimicrobial drugs and has a propensity to cause nosocomial outbreaks. Antiseptic and topical antimicrobial compounds constitute major resources for burns care but in vitro testing of their activity is not performed in practice.

resultsIn our burn unit, a P. aeruginosa clone multiresistant to antibiotics colonized or infected 26 patients over a 2-year period. This resident clone was characterized by PCR based on ERIC sequences. We investigated the susceptibility of the resident clone to silver sulphadiazine and to the main topical antimicrobial agents currently used in the burn unit. We proposed an optimized diffusion assay used for comparative analysis of P. aeruginosa strains. The resident clone displayed lower susceptibility to silver sulphadiazine and cerium silver sulphadiazine than strains unrelated to the resident clone in the unit or unrelated to the burn unit.

conclusionsThe diffusion assay developed herein detects differences in behaviour against antimicrobials between tested strains and a reference population. The method could be proposed for use in semi-routine practice of medical microbiology.

Indexed as

Anti-Bacterial AgentsAnti-Infective Agents, LocalBurnsCross InfectionDisk Diffusion Antimicrobial TestsHumansPseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsAnti-Infective Agents, Local

Identifiers

PMID21702921
PMCPMC3146812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.